申请人:Eli Lilly and Company
公开号:US07335660B2
公开(公告)日:2008-02-26
This invention relates to compounds of formula (I)
where R1 to R12, —W—V—, —X—Y—, p and n have the values defined in claim 1, their preparation and use as pharmaceuticals for the treatment of central nervous system disorders, such as depression, bipolar disorder, and anxiety.
本发明涉及公式(I)的化合物,其中R1至R12,-W-V-,-X-Y-,p和n具有声明1中定义的值,以及它们的制备和用作药物治疗中枢神经系统疾病,如抑郁症、双相情感障碍和焦虑症。